Skip to main content
Top
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren’s contractures of the fingers (HAND-1): study protocol for a randomised controlled trial

Authors: Eleanor Harrison, Wei Tan, Nicola Mills, Alexia Karantana, Kirsty Sprange, Lelia Duley, Daisy Elliott, Jane Blazeby, William Hollingworth, Alan A. Montgomery, Tim Davis

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Dupuytren’s contractures are fibrous cords under the skin of the palm of the hand. The contractures are painless but cause one or more fingers to curl into the palm, resulting in loss of function. Standard treatment within the NHS is surgery to remove (fasciectomy) or divide (fasciotomy) the contractures, and the treatment offered is frequently determined by surgeon preference. This study aims to determine the feasibility of conducting a large, multicentre randomised controlled trial to assess the clinical and cost-effectiveness of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren’s contracture.

Methods/design

HAND-1 is a parallel, two-arm, multicentre, randomised feasibility trial. Eligible patients aged 18 years or over who have one or more fingers with a Dupuytren’s contracture of more than 30° in the metacarpophalangeal (MCP) and/or proximal interphalangeal (PIP) joints, well-defined cord(s) causing contracture, and have not undergone previous surgery for Dupuytren’s on the same hand will be randomised (1:1) to treatment with either needle fasciotomy or limited fasciectomy. Participants will be followed-up for up to 6 months post surgery. Feasibility outcomes include number of patients screened, consented and randomised, adherence with treatment, completion of follow-up and identification of an appropriate patient-reported outcome measure (PROM) to use as primary outcome for a main trial. Embedded qualitative research, incorporating a QuinteT Recruitment Intervention, will focus on understanding and optimising the recruitment process, and exploring patients’ experiences of trial participation and the interventions.

Discussion

This study will assess whether a large multicentre trial comparing the clinical and cost-effectiveness of needle fasciotomy and limited fasciectomy for the treatment of Dupuytren’s contractures is feasible, and if so will provide data to inform its design and successful conduct.

Trial registration

International Standard Registered Clinical/soCial sTudy Number: ISRCTN11164292. Registered on 28 August 2015.
Appendix
Available only for authorised users
Literature
1.
go back to reference Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren’s disease: a study of 30,330 Danish twin pairs. The Journal of hand surgery, European volume. 2015;40(2):171–6. doi:10.1177/1753193414535720.CrossRefPubMed Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren’s disease: a study of 30,330 Danish twin pairs. The Journal of hand surgery, European volume. 2015;40(2):171–6. doi:10.​1177/​1753193414535720​.CrossRefPubMed
4.
go back to reference Engstrand C, Boren L, Liedberg GM. Evaluation of activity limitation and digital extension in Dupuytren’s contracture three months after fasciectomy and hand therapy interventions. Journal of hand therapy. 2009;22(1):21–6. doi:10.1016/j.jht.2008.08.003. quiz 7.CrossRefPubMed Engstrand C, Boren L, Liedberg GM. Evaluation of activity limitation and digital extension in Dupuytren’s contracture three months after fasciectomy and hand therapy interventions. Journal of hand therapy. 2009;22(1):21–6. doi:10.​1016/​j.​jht.​2008.​08.​003. quiz 7.CrossRefPubMed
5.
go back to reference Rodrigues JN, Zhang W, Scammell BE, Davis TR. What patients want from the treatment of Dupuytren’s disease—is the Unite Rhumatologique des Affections de la Main (URAM) scale relevant? The Journal of hand surgery. European volume. 2015;40(2):150–4. doi:10.1177/1753193414524689.CrossRef Rodrigues JN, Zhang W, Scammell BE, Davis TR. What patients want from the treatment of Dupuytren’s disease—is the Unite Rhumatologique des Affections de la Main (URAM) scale relevant? The Journal of hand surgery. European volume. 2015;40(2):150–4. doi:10.​1177/​1753193414524689​.CrossRef
6.
go back to reference Gerber RA, Perry R, Thompson R, Bainbridge C. Dupuytren’ contracture: a retrospective database analysis to assess clinical management and costs in England. BMC Musculoskeletal Disorders. 2011;12(1):1–10. doi:10.1186/1471-2474-12-73.CrossRef Gerber RA, Perry R, Thompson R, Bainbridge C. Dupuytren’ contracture: a retrospective database analysis to assess clinical management and costs in England. BMC Musculoskeletal Disorders. 2011;12(1):1–10. doi:10.​1186/​1471-2474-12-73.CrossRef
7.
go back to reference Bebbington E, Furniss D. Linear regression analysis of Hospital Episode Statistics predicts a large increase in demand for elective hand surgery in England. Journal of plastic, reconstructive & aesthetic surgery. 2015;68(2):243–51. doi:10.1016/j.bjps.2014.10.011.CrossRef Bebbington E, Furniss D. Linear regression analysis of Hospital Episode Statistics predicts a large increase in demand for elective hand surgery in England. Journal of plastic, reconstructive & aesthetic surgery. 2015;68(2):243–51. doi:10.​1016/​j.​bjps.​2014.​10.​011.CrossRef
10.
go back to reference van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. The Journal of hand surgery. 2006;31(5):717–25. doi:10.1016/j.jhsa.2006.02.021.CrossRefPubMed van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. The Journal of hand surgery. 2006;31(5):717–25. doi:10.​1016/​j.​jhsa.​2006.​02.​021.CrossRefPubMed
11.
go back to reference van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plastic and reconstructive surgery. 2012;129(2):469–77. doi:10.1097/PRS.0b013e31823aea95.CrossRefPubMed van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plastic and reconstructive surgery. 2012;129(2):469–77. doi:10.​1097/​PRS.​0b013e31823aea95​.CrossRefPubMed
14.
go back to reference van Rijssen AL, Werker PM. Percutaneous needle fasciotomy for recurrent Dupuytren disease. The Journal of hand surgery. 2012;37(9):1820–3.CrossRefPubMed van Rijssen AL, Werker PM. Percutaneous needle fasciotomy for recurrent Dupuytren disease. The Journal of hand surgery. 2012;37(9):1820–3.CrossRefPubMed
15.
go back to reference Rodrigues JN, Zhang W, Scammell BE, Chakrabarti I, Russell PG, Fullilove S, et al. Functional outcome and complications following surgery for Dupuytren’s disease: a multi-centre cross-sectional study. Journal of Hand Surgery (European Volume). 2016. doi:10.1177/1753193416660045. Rodrigues JN, Zhang W, Scammell BE, Chakrabarti I, Russell PG, Fullilove S, et al. Functional outcome and complications following surgery for Dupuytren’s disease: a multi-centre cross-sectional study. Journal of Hand Surgery (European Volume). 2016. doi:10.​1177/​1753193416660045​.
16.
17.
go back to reference Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice. BMC Musculoskeletal Disorders. 2013;14(1):1–11. doi:10.1186/1471-2474-14-131.CrossRef Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren’s disease: a systematic review and recommendations for future practice. BMC Musculoskeletal Disorders. 2013;14(1):1–11. doi:10.​1186/​1471-2474-14-131.CrossRef
18.
go back to reference Donovan JL, Rooshenas L, Jepson M, Elliott D, Wade J, Avery K, et al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). Trials. 2016;17(1):1.CrossRef Donovan JL, Rooshenas L, Jepson M, Elliott D, Wade J, Avery K, et al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). Trials. 2016;17(1):1.CrossRef
19.
go back to reference Beaudreuil J, Allard A, Zerkak D, Gerber RA, Cappelleri JC, Quintero N, et al. Unite Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren’s disease-specific disability. Arthritis care & research. 2011;63(10):1448–55. doi:10.1002/acr.20564.CrossRef Beaudreuil J, Allard A, Zerkak D, Gerber RA, Cappelleri JC, Quintero N, et al. Unite Rhumatologique des Affections de la Main (URAM) scale: development and validation of a tool to assess Dupuytren’s disease-specific disability. Arthritis care & research. 2011;63(10):1448–55. doi:10.​1002/​acr.​20564.CrossRef
22.
go back to reference Macey AC, Burke FD, Abbott K, Barton NJ, Bradbury E, Bradley A, et al. Outcomes of hand surgery. British Society for Surgery of the Hand. Journal of hand surgery (Edinburgh, Scotland). 1995;20(6):841–55.CrossRef Macey AC, Burke FD, Abbott K, Barton NJ, Bradbury E, Bradley A, et al. Outcomes of hand surgery. British Society for Surgery of the Hand. Journal of hand surgery (Edinburgh, Scotland). 1995;20(6):841–55.CrossRef
23.
go back to reference Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ (Clinical research ed). 1996;312(7037):1016–20.CrossRef Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ (Clinical research ed). 1996;312(7037):1016–20.CrossRef
24.
go back to reference Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5 L Value Set for England. 2016. Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5 L Value Set for England. 2016.
25.
go back to reference Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ (Clinical research ed). 2016;355. doi:10.1136/bmj.i5239. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ (Clinical research ed). 2016;355. doi:10.​1136/​bmj.​i5239.
26.
go back to reference Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of internal medicine. 2008;148(4):295–309.CrossRefPubMed Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of internal medicine. 2008;148(4):295–309.CrossRefPubMed
30.
go back to reference Patton MQ. Qualitative evaluation and research methods. Thousand Oaks: SAGE Publications, inc; 1990. Patton MQ. Qualitative evaluation and research methods. Thousand Oaks: SAGE Publications, inc; 1990.
31.
go back to reference Avery KN, Metcalfe C, Berrisford R, Barham CP, Donovan JL, Elliott J, et al. The feasibility of a randomized controlled trial of esophagectomy for esophageal cancer—the ROMIO (Randomized Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial. Trials. 2014;15(1):1–10. doi:10.1186/1745-6215-15-200.CrossRef Avery KN, Metcalfe C, Berrisford R, Barham CP, Donovan JL, Elliott J, et al. The feasibility of a randomized controlled trial of esophagectomy for esophageal cancer—the ROMIO (Randomized Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial. Trials. 2014;15(1):1–10. doi:10.​1186/​1745-6215-15-200.CrossRef
32.
go back to reference Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials. 2011;12:78. doi:10.1186/1745-6215-12-78.CrossRefPubMedPubMedCentral Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL. Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011). Trials. 2011;12:78. doi:10.​1186/​1745-6215-12-78.CrossRefPubMedPubMedCentral
Metadata
Title
A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren’s contractures of the fingers (HAND-1): study protocol for a randomised controlled trial
Authors
Eleanor Harrison
Wei Tan
Nicola Mills
Alexia Karantana
Kirsty Sprange
Lelia Duley
Daisy Elliott
Jane Blazeby
William Hollingworth
Alan A. Montgomery
Tim Davis
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2127-9

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue